CNS Pharmaceuticals (CNSP) Q1 2026 Annual Earnings
CNSP·Reported May 14, 2026·After market close
Diluted EPS came in at $-7.30, missed the $-5.37 consensus by $1.93.
Diluted EPS
$-7.30missed by $1.93
Consensus: $-5.37
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about CNS Pharmaceuticals's Q1 2026 earnings report.
CNS Pharmaceuticals (CNSP) reported Q1 2026 earnings on May 14, 2026 after market close.
CNS Pharmaceuticals reported diluted EPS of $-7.30 for Q1 2026.
EPS missed the consensus estimate of $-5.37 by $1.93.
You can read the 10-K periodic report (0001683168-26-002550) directly on SEC EDGAR. The filing index links above go to sec.gov.